Dáil Éireann Debate, Thursday - 9 November 2017
197. Deputy Carol Nolan asked the Minister for Health further to Parliamentary Question No. 951 of 26 July 2017, the status of the provision of the drug Spinraza to persons with muscular atrophy; and if he will make a statement on the matter. [47520/17]
View answerThe HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
